乳酸菌联合氯喹那多-普罗雌烯阴道给药治疗萎缩性阴道炎高龄患者的临床观察

Clinical Observation of Vaginal Administration of Lactobacillus Combined with Chlorquinaldol-promestriene for Senile Patients with Atrophic Vaginitis

目的:探讨乳酸菌联合氯喹那多-普罗雌烯阴道给药治疗萎缩性阴道炎高龄患者的疗效及复发率。方法:选取萎缩性阴道炎高龄患者150例。按照随机数字表法分为A、B、C组,各50例。A组患者给予乳酸菌阴道胶囊2粒,qd(睡前);B组患者给予氯喹那多-普罗雌烯阴道片1片,qd(睡前);C组患者给予氯喹那多-普罗雌烯阴道片1片,qd(睡前),次日晨起给予乳酸菌阴道胶囊2粒,qd,均置入阴道深部。3组患者治疗时间均为18 d。观察3组患者临床疗效、阴道健康评分、阴道症状评分和阴道p H值,记录不良反应发生情况和随访期(12个月)复发率。结果:C组患者的临床总有效率(94.00%)明显高于A组(72.00%)和B组(74.00%),差异有统计学意义(P<0.05)。治疗前,3组患者的阴道健康评分、阴道症状评分和阴道p H值比较,差异均无统计学意义(P>0.05)。治疗后,3组患者的阴道健康评分均明显升高,阴道症状评分均明显降低,阴道p H值均明显降低,且C组患者上述指标改善程度明显优于A组和B组,差异均有统计学意义(P<0.05)。3组患者治疗过程中均未见明显不良反应发生。C组患者的随访期复发率(4.00%)明显低于A组(18.00%)和B组(20.00%),差异均有统计学意义(P<0.05)。结论:乳酸菌联合氯喹那多-普罗雌烯阴道给药治疗萎缩性阴道炎高龄患者,可有效缓解其临床症状和体征,提高阴道清洁度,调节局部p H值,降低复发风险,且安全性较高。

OBJECTIVE：To investigate therapeutic efficacy and recurrence rate of vaginal administration of lactobacillus com-bined with chlorquinaldol-promestriene for senile patients with atrophic vaginitis. METHODS：150 senile patients with atrophic vag-initis were selected and divided into group A,B,C according to random number table,with 50 cases in each group. Group A was given Lactobacillus vaginal capsules,2 capsules,qd （at bedtime）;group B given Chlorquinaldol-promestriene vaginal tablets,1 tablet,qd（at bedtime）;group C given Chlorquinaldol-promestriene vaginal tablets,1 tablet,qd（at bedtime）,and Lactobacillus vaginal capsules,2 capsules,qd,next morning,implanting into vagina. 3 groups received treatment for 18 d. Clinical efficacy, vaginal health score,vaginal symptom score and vaginal pH value were observed in 3 groups,and the occurrence of ADR and re-currence rate during follow-up period （12 months） were recorded. RESULTS：The total effective rate of group C was 94.00%, which was significantly higher than group A（72.00%）and B（74.00%）,with statistical significance（P〈0.05）. Before treatment, there was no statistical significance in vaginal health score,vaginal symptom score and vaginal pH value among 3 groups （P〉0.05）. After treatment,vaginal health score of 3 groups were increased significantly,while vaginal symptom score and vaginal pH value were decreased significantly;and the improvement of above indexes in group C were significantly better than in group A and B,with statistical significance（P〈0.05）. No obvious ADR was found in 3 groups during treatment. The recurrence rate of group C during follow-up period（4.00%）was significantly lower than that of group A（18.00%）and group B（20.00%）,with statistical significance（P〈0.05）. CONCLUSIONS：Vaginal administration of lactobacillus combined with chlorquinaldol-promestriene for se-nile patients with atrophic vaginitis can effectively relieve clinical symptoms and signs,improve vaginal cleanliness,regulate the lo-cal pH value and reduce the risk of recurrence,with good safety.